Knijff
14 IP cases indexed. Covers patent matters.
Cases Presided Over
14 cases indexed | Page 1 of 1
(1) GC AESTHETICS PARENTCO LIMITED, (2) NAGOR LIMITED, (3) GC AESTHETICS MANAGEMENT LIMITED, (4) GC AESTHETICS (DISTRIBUTION) LIMITED, (5) GC AESTHETICS (France) SAS, (6) EUROSILICONE SAS, (7) GC AESTHETICS ITALY S.R.L., (8) GC AESTHETICS GmbH, (9) G v.ESTABLISHMENT LABS S.A.
This procedural order concerns a request by the defendants (a group of GC Aesthetics entities and Romed N.V.) for security for costs under Rule 158 RoP against the claimant Establishment Labs S.A. (LABS) in infringement proceedings concerning EP 3 107 487 B1. The defendants argued that LABS, incorporated in Costa Rica, posed an enforcement risk because Costa Rica had not ratified the Hague Judgement Convention and there was no precedent for enforcing UPC costs orders there. The Court ordered LABS to provide security of €600,000 within 21 days, either by deposit into a UPC account or by bank guarantee from an EU-licensed bank.
Neurocrine Biosciences, Inc. v.Spruce Biosciences, Inc.
This case concerned a revocation action filed by Neurocrine Biosciences against Spruce Biosciences's European patent EP 3 784 233, relating to methods for treating testicular and ovarian adrenal rest tumors. During the proceedings, the European Patent Office Opposition Division revoked the patent in its entirety for lack of novelty, and Spruce chose not to appeal. The Court disposed of the revocation action as devoid of purpose under R. 360 RoP, awarded Neurocrine 80% of the maximum recoverable costs (EUR 488,000), and ordered partial reimbursement of court fees.
Canon Kabushiki Kaisha v.Katun Germany GmbH. a. o.
Canon Kabushiki Kaisha sued Katun Germany GmbH, Katun (E.D.C.) B.V., Katun Corporation, and General Plastic Industrial Co., Ltd. for infringement of European Patent EP 3 686 683 B1, which relates to a developer replenishing container and system. The Düsseldorf Local Division found that the defendants' toner bottles infringed the patent, dismissed the defendants' counterclaim for revocation, and ordered injunctive relief, recall and destruction of infringing products, damages, and publication of the operative part of the decision on the defendants' websites.
GXD-Bio Corporation v.Myriad International GmbH a.o.
GXD-Bio Corporation, the registered owner of European Patent EP 3 346 403 concerning a method for quantifying gene expression in FFPE breast cancer tissue samples using OAZ1 as an endogenous reference gene, sued multiple Myriad entities and Eurobio Scientific for patent infringement relating to the EndoPredict test. The defendants filed a counterclaim for revocation, and GXD-Bio sought to amend the patent via three auxiliary claim requests. The Local Division Munich revoked the patent, dismissed the amendment application, and dismissed the infringement action, finding that the EndoPredict test did not infringe because it uses three reference genes (CALM2, OAZ1, and RPL37A) for normalization rather than OAZ1 alone as required by claim 1.
Centripetal Limited v.Keysight Technologies, Inc. et. al.
Centripetal Limited, the registered and sole proprietor of European Patent EP 3 821 580 B1 relating to Methods and Systems for Efficient Network Protection, sued Keysight Technologies, Inc. and Keysight Technologies Deutschland GmbH for direct infringement of Claim 16 and indirect infringement of Claim 1 of the patent in Germany, Italy, France, and the Netherlands. The patent was granted and published on 29 May 2024, and the prior opt-out was withdrawn from the register on 12 July 2024. The case was heard by a panel of the Local Division Mannheim on 9 October 2025, with a decision delivered on 5 December 2025.
Malikie Innovations Ltd. v.Nintendo Co., Ltd. a.o.
This is a procedural order from the Local Division Hamburg in an infringement action and counterclaim for revocation concerning European Patent EP2579551, owned by Malikie Innovations Ltd. against Nintendo Co., Ltd. and Nintendo of Europe SE. The order summarizes the interim conference held on 22 October 2025, addressing procedural matters including the value of the case, reimbursement of legal costs, parallel proceedings status, the claimant's operational request regarding the counterclaim for revocation, and the admissibility of certain evidence and claim amendments. The judge-rapporteur admitted the Patent Sale Agreement and Patent Assignment Agreement as exhibits and granted leave to amend the patent claims under Rule 263 RoP.
Prinoth S.p.A. v.Xelom s.r.l.
1 di 18 TRIBUNALE UNIFICATO DEI BREVETTI TRIBUNALE DI PRIMO GRADO DIVISIONE LOCALE DI MILANO UPC CFI n. 127/2025 ORDINANZA SULLA RICHIESTA DI RIESAME DELL’ORDINE DI PROTEZIONE DELLA PROVA, DI ISPEZIONE E DI SEQUESTRO depositata in data 27 ottobre 2025 NOTE 1. Ai fini della conce
Centripetal Limited v.Respondent
The Local Division Mannheim issued a procedural order confirming the judge-rapporteur's earlier decision to reject the Claimant's request to submit a further written pleading on infringement. The Claimant, Centripetal Limited, sought to introduce a new infringement reading based on an alleged newly discovered functionality of the attacked embodiment, but the panel held that allowing such a submission at this late stage would prejudice the Defendants and disrupt the scheduled oral hearing. The panel further barred the Claimant from introducing a fifth infringement reading, noting that the relevant functionalities had been known to the Claimant since 2023 ITC proceedings and since the March 2025 launch of the Defendants' AI Stack.
bioMérieux Deutschland GmbH, bioMérieux Italia S.p.A., bioMérieux SA, bioMérieux Austria GmbH, bioMérieux Benelux BV, bioMérieux Portugal, Lda. v.Labrador Diagnostics LLC
This procedural order concerns two related revocation cases before the Court of First Instance, Central Division Milan, involving European Patent EP 3 756 767 B1 owned by Labrador Diagnostics LLC. The court addressed procedural matters following an interim conference, including an opposition filed by bioMérieux France, confirmation of exhibits, and the management of an excessive number of invalidity attacks. The court directed bioMérieux to narrow its inventive step attacks and focus on specific added matter arguments, while structuring the upcoming oral hearing and setting deadlines for further submissions.
bioMérieux UK Limited v.Labrador Diagnostics LLC
This Procedural Order was issued by the Court of First Instance, Central Division Milan, on 18 July 2025, managing two related revocation proceedings concerning European Patent EP 3 756 767 B1 owned by Labrador Diagnostics LLC. The court addressed the management of bioMérieux's extensive invalidity attacks (approximately 50 attacks based on 16 prior art citations) and directed bioMérieux to narrow its arguments, preferably to three inventive step attacks and specific added matter features. The court also set deadlines for submissions and preliminary cost estimates, and outlined the structure of the upcoming oral hearing.
SICHUAN YUANXING RUBBER CO., LTD. v.Respondent
1 di 5 Divisione Locale di Milano UPC CFI n. 770/2024 Act. n. 64425/2024 App. n. 26266/2025 ordinanza n. 26742/2025 depositata il 14.7.2025 ATTORE Pirelli Tyre s.p.a. CONVENUTI 1) Sichuan Yuanxing Rubber co. Ltd. 2) China Council for the Promotion of International Trade, Automot
Canon Kabushiki Kaisha v.General Plastic Industrial Co., Ltd., Katun Germany GmbH, Katun Corporation, Katun (E.D.C.) B.V.
Procedural order issued by the Düsseldorf Local Division concerning European Patent EP 3 686 683 B1, addressing the question of bifurcation under Article 33(3) UPCA. The court decided to hear both the patent infringement action and the counterclaim for revocation jointly, with the consent of all parties, for reasons of efficiency and to ensure a uniform interpretation of the patent.
PRINOTH S.P.A. v.XELOM S.R.L.
Prinoth S.p.A., a world leader in the production of snow groomers and tracked vehicles, sought an ex parte order for preservation of evidence, inspection, and seizure against Xelom S.r.l., an innovative start-up belonging to the Technoalpin group. Prinoth alleged that Xelom's newly developed electric snow groomer (Snow Cat), which had been deployed at several ski resorts in Austria, South Tyrol, Trento, Stockholm, and Bolzano, infringed its European patents EP1995159 and EP2507436 relating to snow groomers and their control methods. The Presiding Judge determined that the conditions for extreme urgency were not met and appointed a Judge Rapporteur to convene the applicant for further clarifications regarding documents and search keywords.
Fapa Vital AG v.Respondent
Fapa Vital AG filed an application for provisional measures against Valentis Baltic UAB concerning EP 1 978 949 before the Nordic-Baltic Regional Division of the Unified Patent Court. After the parties reached a settlement, the Applicant withdrew the application and requested reimbursement of 60% of the Court fees. The Court declared the proceedings closed and ordered reimbursement of EUR 6,600 (60% of the EUR 11,000 total Court fees), applying Rule 370.9(b) RoP by analogy to the withdrawal of an application for provisional measures.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.